A Systematic Review on TST and IGRA Tests Used for Diagnosis of LTBI in Immigrants

Molecular Diagnosis and Therapy

Volumn 19, Issue 1, 2015, Pages 9-24

  Campbell, Jonathon R ^a   Krot, Jane ^a   Elwood, Kevin ^b   Cook, Victoria ^a,b   Marra, Fawziah ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINATION; BIBLIOGRAPHIC DATABASE; CHECKLIST; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSPOT ASSAY; GOLD STANDARD; HEALTH CARE QUALITY; HUMAN; IMMIGRANT; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; META ANALYSIS; NONHUMAN; POPULATION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TUBERCULIN TEST; ADOLESCENT; ADULT; AFRICA; AGE; ASIA; CHILD; ENDEMIC DISEASE; IMMUNOLOGY; INFANT; MALE; MICROBIOLOGY; MIDDLE AGED; MIDDLE EAST; MIGRANT; NEWBORN; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; AFRICA; AGE FACTORS; ASIA; CHILD; CHILD, PRESCHOOL; EMIGRANTS AND IMMIGRANTS; ENDEMIC DISEASES; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MIDDLE EAST; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST;

EID: 84925503041     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.1007/s40291-014-0125-0     Document Type: Review

References (81)

1. Global tuberculosis report 2012. Switzerland: World Health Organization; 2012. Available: http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf. Accessed 26 May 2014.
2. Sudre P, ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bull World Organ. 1992;70:149–59.
3. Nathanson E, Nunn P, Uplekar M, et al. MDR tuberculosis—critical steps for prevention and control. N Engl J Med. 2010;363(11):1050–8.
4. Raviglione MC, Smith IM. XDR tuberculosis—implications for global public health. N Engl J Med. 2007;356(7):656–9.
5. Raviglione MC, Snider D, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA. 1995;273(3):220–6.
6. Pareek M, Baussano I, Abubakar I, et al. Evaluation of immigrant tuberculosis screening in industrialized countries. Emerg Infect Dis. 2012;18(9):1422–9.
7. Alvarez GG, Gushulak B, Abu Rumman K, et al. A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates. BMC Infect Dis. 2011;11:3.
8. Canadian tuberculosis standards. 7th edn. Ottawa (ON): Canadian Thoracic Society; 2013. Available: http://www.respiratoryguidelines.ca/tb-standards-2013. Accessed 26 May 2014.
9. Klinkenberg E, Manissero D, Semenza JC, et al. Migrant tuberculosis screening in the EU/EEA: yield, coverage and limitations. Eur Respir J. 2009;34(5):1180–9.
10. Walter ND, Painter J, Parker M, et al. Persistent latent tuberculosis reactivation risk in United States immigrants. Am J Resp Crit Care Med. 2014;189(1):88–95.
11. Cohen T, Murray M. Incidence tuberculosis among recent US immigrants and exogenous reinfection. Emerg Infect Dis. 2005;11(5):725–8.
12. Latent tuberculosis infection: a guide for primary health care providers. Atlanta (GA): Centers for Disease Control and Prevention; 2013. Available: http://www.cdc.gov/tb/publications/ltbi/diagnosis.htm. Accessed 26 May 2014.
13. Jerant AF, Bannon M, Rittenhouse S. Identification and management of tuberculosis. Am Fam Physician. 2000;61(19):2667–78.
14. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146(5):340–54.
15. Mazurek GH, Villarino ME. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003;52(RR-2):15–18.
16. Chee CB, KhinMar KW, Gan SH, et al. Latent tuberculosis infection treatment and T-cell responses to mycobacterium tuberculosis-specific antigens. Am J Resp Crit Care. 2007;175(3):282–7.
17. Arshad S, Bavan L, Gajari K, et al. Active screening at entry for tuberculosis among new immigrants: a systematic review and meta-analysis. Eur Respir J. 2010;35(6):1336–45.
18. Munoz L, Santin M. Interferon-gamma release assays versus tuberculin skin test for targeting people for tuberculosis preventive treatment: an evidence-based review. J Infect. 2013;66(4):381–7.
19. Joos TJ, Miller WC, Murdoch DM. Tuberculin reactivity in bacille Calmette–Guerin vaccinated populations: a compilation of international data. Int J Tuberc Lung Dis. 2006;10(8):883–91.
20. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Med. 2009;6(7):e1000097.
21. Critical Appraisal. Methodology Checklist 5: Diagnostic Studies. Scotland: SIGN; 2013. Available: http://www.sign.ac.uk/methodology/checklists.html. Accessed 26 May 2014.
22. Framework towards TB elimination in low-incidence Countries. Switzerland: World Health Organization; 2014. Available: http://apps.who.int/iris/bitstream/10665/132231/1/9789241507707_eng.pdf?ua=1. Accessed 21 Oct 2014.
23. Levesque J, Dongier P, Brassard P, et al. Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada. Int J Tuberc Lung Dis. 2004;8(6):711–7.
24. Trauer J, Krause V. Assessment and management of latent tuberculosis infection in a refugee population in the Northern Territory. MJA. 2011;194(11):578–82.
25. Lifson A, Thai D, O’Fallon A, et al. Prevalence of tuberculosis, hepatitis B virus, and intestinal parasitic infections among refugees to Minnesota. Pub Health Reports. 2002;117:69–77.
26. Tafuri S, Martinelli D, Melpignano L, et al. Tuberculosis screening in migrant reception centers: results of a 2009 Italian survey. Am J Infect Control. 2011;39(6):495–9.
27. Sanfrancisco M, Portillo J, Romero J, et al. Prevalence of tuberculosis infection in the population of immigrants in Ceuta, Spain. Rev Esp Salud Publica. 2001;75(6):551–8.
28. Perez-Stable E, Slutkin G, Paz E, et al. Tuberculin reactivity in United States and foreign-born Latinos: results of a community-based screening program. Am J Pub Health. 1986;76(6):643–6.
29. Menzies R, Vissandjee B, Amyot D. Factors associated with tuberculin reactivity among the foreign-born in Montreal. Am Rev Respir Dis. 1992;148:752–8.
30. El-Hamad I, Cadalini C, Matteelli A, et al. Screening for tuberculosis and latent tuberculosis infection among undocumented immigrants at an unspecialized health service unit. Int J Tuberc Lung Dis. 2001;5(8):712–6.
31. Asgary R, Naderi R, Swedish KA, et al. Communicable and non-communicable diseases among recent immigrants with implications for primary care; a comprehensive immigrant health approach. J Immigr Minor Health. 2011;13:990–5.
32. Robertson JM, Burtt DS, Edmonds KL, et al. Delayed tuberculin reactivity in persons of indochinese origin: implications for preventive therapy. Ann Intern Med. 1996;124(9):779–84.
33. Padovese V, Egidi AM, Melillo TF, et al. Prevalence of latent tuberculosis, syphilis, hepatitis B and C among asylum seekers in Malta. J Pub Health. 2014;36(1):22–7.
34. Carvalho ACC, Saleri N, El-Hamad I, et al. Completion of screening for latent tuberculosis infection among immigrants. Epidemiol Infect. 2005;133(1):179–85.
35. Alperstein G, Morgan K, Fett M, et al. Prevalence of tuberculosis infection among primary school-entry children in Sydney. Aus NZ J Pub Health. 1996;20(2):123–8.
36. Minodier P, Lamarre V, Carle ME, et al. Evaluation of a school-based program for diagnosis and treatment of latent tuberculosis infection in immigrant children. J Infect Pub Health. 2010;3(2):67–75.
37. Geltman P, Radin M, Zhang Z, et al. Growth status and related medical conditions among refugee children in Massachusetts, 1995–1998. Am J Pub Health. 2001;91(11):1800–5.
38. Sheikh M, Pal A, Want S, et al. The epidemiology of health conditions of newly arrived refugee children: a review of patients attending a specialist health clinic in Sydney. J Ped Child Health. 2009;49:509–13.
39. Gray K, Wood N, Gunasekera H, et al. Vitamin D and tuberculosis status in refugee children. Ped Infec Dis J. 2012;31(5):521–3.
40. Losi M, Bergamini BM, Venturelli C, et al. Tuberculosis infection in foreign-born children: a screening survey based on skin and blood testing. Int J Tuberc Lung Dis. 2011;15(9):1182–4.
41. Hladun O, Grau A, Esteban E, et al. Results from screening immigrants of low-income countries: data from a public primary health care. J Travel Med. 2013;21(2):92–8.
42. Baussano I, Mercadante S, Pareek M, et al. High rates of mycobacterium tuberculosis among socially marginalized immigrants in low-incidence area, 1991–2010, Italy. Emerg Infec Dis. 2013;19(9):1437–45.
43. Kowatsch-Beyer K, Norris-Turner A, Love R, et al. Utilization of a latent tuberculosis infection referral system by newly resettled refugees in central Ohio. Int J Tuberc Lung Dis. 2013;17(3):320–5.
44. Martin J, Mak D. Changing faces: a review of infectious disease screening of refugees by the Migrant Health Unit, Western Australia in 2003 and 2004. MJA. 2006;185(11):607–10.
45. Varkey P, Jerath A, Bagniewski S, et al. The epidemiology of tuberculosis among primary refugee arrivals in minnesota between 1997 and 2001. J Travel Med. 2007;14(1):1–8.
46. MacIntyre C, Plant A. Longitudinal incidence of tuberculosis in South-East Asian refugees after re-settlement. Int J Tuberc Lung Dis. 1999;3(4):287–93.
47. Chai S, Davies-Cole J, Cookson S. Infectious disease burden and vaccination needs among asylees versus refugees, District of Columbia. Clin Infect Dis. 2013;56:652–8.
48. Hobbs M, Moor C, Wansbrough T, et al. The health status of asylum seekers screened by Auckland Public Health in 1999 and 2000. NZ Med J. 2002;115(1160):U152.
49. Bran C, Gomez J, Cayia J, et al. Factors associated with latent tuberculosis infection in immigrants less than 35 years old. Enferm Infect Microbiol Clin. 2006;24(5):322–5.
50. Li J, Munsiff S, Agerton T. Prevalence of tuberculin skin test positivity in clinical population in New York City. J Immigr Minor Health. 2010;12(6):816–22.
51. Desale M, Bringardner P, Fitzgerald S, et al. Intensified case-finding for latent tuberculosis infection among the Baltimore City Hispanic Population. J Immigr Minor Health. 2013;15(4):680–5.
52. Truong DH, Hedemark LL, Mickman JK, et al. Tuberculosis among Tibetan immigrants from India and Nepal in Minnesota, 1992–1995. JAMA. 1997;277(9):735–8.
53. Mulder C, Mulleners B, Borgdorff M, et al. Predictive value of the tuberculin skin test among newly arriving immigrants. PLoS One. 2013;8(3):e60130.
54. Hayes E, Talbot SB, Matheson ES, et al. Health status of pediatric refugees in Portland, Me. Arch Pediatr Adolesc Med. 1998;152:564–8.
55. Fortin K, Carceller A, Robert M, et al. Prevalence of positive tuberculin skin tests in foreign-born children. J Paediatr Child Health. 2007;43(11):768–72.
56. Brassard P, Steensma C, Cadieux L, et al. Evaluation of a school-based tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country. Pediatrics. 2006;117(2):e148–56.
57. Bodenmann P, Vaucher P, Wolff H, et al. Screening for latent tuberculosis infection among undocumented immigrants in Swiss healthcare centres; a descriptive exploratory study. BMC Infect Dis. 2009;9:34.
58. Pareek M, Watson JP, Ormerod LP, et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicenter cohort study and cost-effectiveness analysis. Lancet Infect Dis. 2011;11:435–44.
59. ®-TB In-Tube assay in screening new immigrants for tuberculosis infection. Eur Respir J. 2012;40(6):1443–9.
60. Garfein RS, Burgos JL, Rodriguez-Lainz A, et al. Latent tuberculosis infection in a migrant agricultural community in Baja California, Mexico. J Immigr Minor Health. 2011;13:940–7.
61. Harstad I, Winje B, Heldal E, et al. Predictive values of QuantiFERON-TB Gold testing in screening for tuberculosis disease in asylum seekers. Int J Tuberc Lung Dis. 2010;14(9):1209–11.
62. Bennett RJ, Brodine S, Waalen J, et al. Prevalence and treatment of latent tuberculosis infection among newly arrived refugees in San Diego Country, January 2010–October 2012. Am J Pub Health. 2014;104(4):e95–102.
63. Banfield S, Pascoe E, Thambiran A, et al. Factors associated with the performance of a blood-based interferon-gamma release assay in diagnosing tuberculosis. PLoS One. 2012;7(6):e38556.
64. Simpson T, Tomaro J, Jobb C. Implementation of an interferon-gamma release assay to screen for tuberculosis in refugees and immigrants. J Immigr Minor Health. 2013;15(4):686–92.
65. Paxton G, Sangster K, Maxwell E, et al. Post-arrival health screening in karen refugees in Australia. PLoS One. 2012;7(5):e38194.
66. Orlando G, Merli S, Cordier L, et al. Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants. Infection. 2010;38:195–204.
67. Saracino A, Scotto G, Fornabaio C, et al. QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy. New Microbiologica. 2009;32:369–76.
68. Baker C, Thomas W, Stauffer W, et al. Serial testing of refugees for latent tuberculosis using the QuantiFERON-Gold In-Tube: effects of an antecedent tuberculin skin test. Am J Trop Med Hyg. 2009;80(4):628–33.
69. Weinfurter P, Blumberg HM, Goldbaum G, et al. Predictors of discordant tuberculin skin test and QuantiFERON-TB In-Tube results in various high-risk groups. Int J Tuberc Lung Dis. 2011;15(8):1056–61.
70. Pottumarthy S, Morris A, Harrison A, et al. Evaluation of the tuberculin gamma interferon assay: potential to replace the mantoux skin test. J Clin Microbiol. 1999;37(10):3229–32.
71. Carvalho AC, Pezzoli MC, El-Hamad I, et al. QuantiFERON-TB Gold test in the identification of latent tuberculosis infection in immigrants. J Infect. 2007;55(2):164–8.
72. Winje BA, Oftung F, Korsvold GE, et al. Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERON-TB Gold with tuberculin skin test. BMC Infect Dis. 2008;8:65.
73. Painter JA, Graviss EA, Hai HH, et al. Tuberculosis screening by tuberculosis skin test of QuantiFERON®-TB Gold In-Tube Assay among an immigrant population with a high prevalence of tuberculosis and BCG vaccination. PLoS One. 2013;8(12):e82727.
74. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Manchester (UK): National Institute for Health and Care Excellence; 2011. http://www.nice.org.uk/guidance/cg117. Accessed 26 May 2014.
75. Greenaway C, Sandoe A, Vissandjee B, et al. Tuberculosis: evidence review for newly arriving immigrants and refugees. CMAJ. 2011;183(12):E939–51.
76. Cain KP, Mac Kenzie WR. Overcoming the limits of tuberculosis prevention among foreign-born individuals: next steps toward eliminating tuberculosis. Clin Infect Dis. 2008;46(1):107–9.
77. Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive value of interferon-y gamma release assays for incidence active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):45–55.
78. Roy A, Eisenhut M, Harris RJ, et al. Effect of BCG vaccination against mycobacterium tuberculosis infection in children: systematic review and meta-analysis. BMJ. 2014;349:g4643.
79. Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-y release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest. 2012;142(1):63–75.
80. Trajman A, Steffen RE, Menzies D. Interferon-gamma release assays versus tuberculin skin testing for the diagnosis of latent tuberculosis infection: an overview of the evidence. Pulm Med. 2013;2013:601737.
81. Bettache N, Schwartzman K, Cnossen S, et al. Effectiveness of post-arrival latent tuberculosis screening programs in the foreign-born: a systematic review and meta-analysis. Am J Resp Crit Care Med. 2012;185:A3325.